Karayiannakis Anastasios J, Kakolyris Stylianos, Kouklakis Georgios, Xenidis Nikolaos, Bolanaki Helen, Tsalikidis Christos, Simopoulos Constantinos
Second Department of Surgery, Democritus University of Thrace, Medical School, Alexandroupolis, Greece.
Case Rep Gastroenterol. 2011 May;5(2):301-7. doi: 10.1159/000329344. Epub 2011 May 28.
Carcinoma of the papilla of Vater is a relatively rare tumor and its coexistence with other primary sporadic cancers is very exceptional. Here we report the case of a 76-year-old man who presented with painless obstructive jaundice, pathologically elevated liver function tests and increased serum levels of carbohydrate antigen 19-9 and carcinoembryonic antigen. Endoscopic retrograde cholangiography revealed a large polypoid mass in the ampulla of Vater. A large tumor in the ascending colon was also incidentally detected by abdominal computed tomography. Endoscopic biopsies from both lesions showed adenocarcinomas. Metastases to the liver and to the hepatoduodenal ligament and hepatic artery lymph nodes were found during surgery. Right colectomy and a biliary bypass were performed. Histological analysis showed an ampullary adenocarcinoma with metastases to regional lymph nodes and the liver and a colonic adenocarcinoma with local invasion into the pericolic fat. Treatment with gemcitabine plus cisplatin was suggested postoperatively. The association of sporadic ampullary and colonic adenocarcinomas and the mutually increased risk of developing either a synchronous or a metachronous tumor following each other should be considered in patients with primary ampullary or colorectal cancer during the preoperative evaluation and postoperative follow-up of these patients.
壶腹癌是一种相对罕见的肿瘤,它与其他原发性散发性癌症共存的情况非常罕见。在此,我们报告一例76岁男性患者,该患者表现为无痛性梗阻性黄疸、肝功能检查病理性升高以及血清糖类抗原19-9和癌胚抗原水平升高。内镜逆行胆管造影显示在 Vater 壶腹有一个大的息肉样肿物。腹部计算机断层扫描还意外发现升结肠有一个大肿瘤。两个病变部位的内镜活检均显示为腺癌。手术中发现有肝转移以及肝十二指肠韧带和肝动脉淋巴结转移。进行了右半结肠切除术和胆肠吻合术。组织学分析显示为壶腹腺癌伴区域淋巴结和肝转移以及结肠腺癌伴局部侵犯结肠周围脂肪。术后建议采用吉西他滨加顺铂治疗。在对原发性壶腹癌或结直肠癌患者进行术前评估和术后随访时,应考虑散发性壶腹癌和结肠癌的关联以及相继发生同步或异时肿瘤的相互增加的风险。